Contract HHSO100201100034C

Elusys Therapeutics Inc · Department Of Health And Human Services · August 30, 2011

Cost Plus Fixed FeeFull & Open CompetitionNAICS 541711

Elusys Therapeutics Inc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on August 30, 2011 for $26.25 million of work in research and development in biotechnology. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses cost-plus contract pricing. The most recent modification was on August 6, 2024. If all options are exercised, the contract could reach $69.59 million.

Obligated to date
$26.25M
$26,249,827
Potential value
$69.59M
if all options exercised
Modifications
1
Latest August 6, 2024

Contract details

PIID
HHSO100201100034C
Award type
Pricing
Cost Plus Fixed Fee
Set-aside
No Set Aside Used.
Competition
Full And Open Competition
NAICS
541711 · Research And Development In Biotechnology
Product / service
Research And Development Facilities
First action
August 30, 2011
Latest action
August 6, 2024

Description

THE PURPOSE OF THIS BILATERAL MODIFICATION IS TO DE-OBLIGATE CANCELING FUNDS FROM REQUISITION OS212728 OF $282,172.97, UPDATE SECTION F.2. DELIVERABLES, AND G.5. INVOICES/FINANCING REQUEST AND CONTRACT FINANCIAL REPORTING.

Modification timeline

  • August 6, 2024
    Mod P00024 · Other Administrative Action
    $62.15M
  • August 30, 2011
    Base award
    $26.53M

Similar contracts

RecipientAgencyDateObligated
Transnetyx, IncDepartment Of Health And Human ServicesJune 25, 2026$18.3K
Deloitte Consulting LlpDepartment Of Health And Human ServicesJune 18, 2026$50.0K
University Of IllinoisDepartment Of Health And Human ServicesMarch 26, 2026$2.27M
Battelle Memorial InstituteDepartment Of Health And Human ServicesMarch 25, 2026$9.65M
University Of Texas Medical Branch At GalvestonDepartment Of Health And Human ServicesMarch 23, 2026$1.61M
Regeneron Pharmaceuticals IncDepartment Of Health And Human ServicesMarch 19, 2026$8.60M

Top contractors in NAICS 541711

Lifetime obligated dollars across all federal contracts in this NAICS code.

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract HHSO100201100034C?

Contract HHSO100201100034C is a federal contract awarded to Elusys Therapeutics Inc by Department Of Health And Human Services on August 30, 2011 for $26.25 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 1 time since the base award.

Who won contract HHSO100201100034C?

Elusys Therapeutics Inc won contract HHSO100201100034C from Department Of Health And Human Services.

How much is contract HHSO100201100034C worth?

Contract HHSO100201100034C has obligated $26.25 million to date, with a total potential value of $69.59 million if all options are exercised.